Sari Maljanen

506 total citations
8 papers, 64 citations indexed

About

Sari Maljanen is a scholar working on Infectious Diseases, Immunology and Health. According to data from OpenAlex, Sari Maljanen has authored 8 papers receiving a total of 64 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Immunology and 1 paper in Health. Recurrent topics in Sari Maljanen's work include SARS-CoV-2 and COVID-19 Research (5 papers), Viral Infections and Outbreaks Research (3 papers) and interferon and immune responses (2 papers). Sari Maljanen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Viral Infections and Outbreaks Research (3 papers) and interferon and immune responses (2 papers). Sari Maljanen collaborates with scholars based in Finland. Sari Maljanen's co-authors include Ilkka Julkunen, Laura Kakkola, Krister Melén, Miao Jiang, Pamela Österlund, Pekka Kolehmainen, Rickard Lundberg, Moona Huttunen, Teemu Smura and Johanna Lempainen and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Virology.

In The Last Decade

Sari Maljanen

7 papers receiving 64 citations

Peers

Sari Maljanen

ID

IMMUN

EPIDE

MB

NEURO

Alexander Anderson United States

Pinja Jalkanen Finland

Zijing Jia China

Pascal Irrgang Germany

Cuixian Yang China

Prajakta Warang United States

Ka-Li Zhu China

Noemi F. Freise Germany

Chaemin Yoon China

Haajira Kaldine South Africa

Alexander Anderson United States

Sari Maljanen

33 ×0.6

ID

24 ×1.2

IMMUN

15 ×1.3

EPIDE

25 ×2.5

MB

3 ×0.6

NEURO

Citations per year, relative to Sari Maljanen Sari Maljanen (= 1×) peers Alexander Anderson

Countries citing papers authored by Sari Maljanen

Since Specialization

Citations

This map shows the geographic impact of Sari Maljanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Maljanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Maljanen more than expected).

Fields of papers citing papers by Sari Maljanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Maljanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Maljanen. The network helps show where Sari Maljanen may publish in the future.

Co-authorship network of co-authors of Sari Maljanen

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Maljanen. A scholar is included among the top collaborators of Sari Maljanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Maljanen. Sari Maljanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Reinholm, Arttu, Hira Khan, T.I. Laakso, et al.. (2025). Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1. Vaccine. 68. 127894–127894.

2.

Reinholm, Arttu, Pekka Kolehmainen, Sari Maljanen, et al.. (2024). Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity. Frontiers in Immunology. 15. 1494432–1494432. 1 indexed citations

3.

Kolehmainen, Pekka, Moona Huttunen, Sari Maljanen, et al.. (2023). Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers. Scientific Reports. 13(1). 8416–8416. 3 indexed citations

4.

Khan, Hira, Moona Huttunen, Pekka Kolehmainen, et al.. (2022). Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation. Frontiers in Immunology. 12. 694105–694105. 11 indexed citations

5.

Jalkanen, Pinja, Pekka Kolehmainen, Moona Huttunen, et al.. (2022). Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination. Microbiology Spectrum. 10(2). e0225221–e0225221. 10 indexed citations

6.

Jiang, Miao, Pekka Kolehmainen, Laura Kakkola, et al.. (2021). SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Microbiology Spectrum. 9(1). e0077421–e0077421. 13 indexed citations

7.

Melén, Krister, Sari Maljanen, Rickard Lundberg, et al.. (2017). Ebolavirus protein VP24 interferes with innate immune responses by inhibiting interferon-λ1 gene expression. Virology. 509. 23–34. 25 indexed citations

8.

Julkunen, Ilkka, et al.. (2015). ID: 71. Cytokine. 76(1). 78–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact